July 21, 2011

Garrison v. Novartis Pharmaceuticals Corporation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 03, 2014

    Novartis Beats Ala. Bone Drug Case On Expert Testimony

    An Alabama federal judge on Wednesday tossed a suit alleging Novartis Pharmaceuticals Corp.'s bone drugs Aredia and Zometa cause bone damage, finding the plaintiff lacks admissible expert testimony to show specific causation.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS